Defunct Company
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
141
NCT02875678
A Study to Evaluate the Effects of ABX-1431 on Patients With Functional Dyspepsia
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 22, 2016
Completion: Aug 7, 2017
NCT02929264
An fMRI Study in Healthy Volunteers to Investigate the Effects of ABX-1431 on Experimental Hyperalgesia and Its Neural Correlates
Start: Dec 31, 2016
Completion: Mar 31, 2018
NCT03058562
A Study to Evaluate the Effects of ABX-1431 on Patients With Tourette Syndrome
Start: Feb 1, 2017
Completion: Oct 4, 2017
NCT03138421
Central Pain Study for ABX-1431
Start: Aug 1, 2017
Completion: Jul 24, 2018
NCT03447756
Titration Study of ABX-1431
Start: Oct 2, 2017
Completion: May 7, 2019
NCT03625453
Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder
Phase: Phase 2
Start: Oct 15, 2018
Completion: Jan 20, 2020